Information Provided By:
Fly News Breaks for March 20, 2017
ZYNE
Mar 20, 2017 | 08:13 EDT
Roth Capital analyst Michael Higgins raised his price target for Zynerba to $30 from $25, citing his increasing confidence in the outcome of STAR 1. The analyst reiterates a Buy rating on the shares.
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.